Biohaven Pharmaceutical Holding Co Ltd. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biohaven Pharmaceutical Holding Co Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Biohaven Pharmaceutical Holding Co Ltd. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 83.38 | 10,000 | 833,800 | 10,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 83.38 | 492 | 41,023 | 2,659 | 3.2 K to 2.7 K (-15.61 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 3,151 | 1.9 K to 3.2 K (+65.75 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 83.38 | 40,000 | 3,335,200 | 40,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 83.38 | 2,124 | 177,099 | 7,127 | 9.3 K to 7.1 K (-22.96 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 5,000 | 0 | 9,251 | 4.3 K to 9.3 K (+117.62 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 1,250 | 0 | 2,187 | 937 to 2.2 K (+133.40 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 5,691 | 7.4 K to 5.7 K (-23.49 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,750 | 0 | 7,438 | 3.7 K to 7.4 K (+101.68 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 7,691 | 9.4 K to 7.7 K (-18.51 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 9,438 | 5.7 K to 9.4 K (+65.93 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 9,211 | 11 K to 9.2 K (-15.94 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,750 | 0 | 10,958 | 7.2 K to 11 K (+52.03 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 10,012 | 11.8 K to 10 K (-14.86 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,750 | 0 | 11,759 | 8 K to 11.8 K (+46.82 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 83.38 | 100,000 | 8,338,000 | 100,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 83.38 | 5,802 | 483,771 | 19,409 | 25.2 K to 19.4 K (-23.01 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 25,211 | 12.7 K to 25.2 K (+98.34 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | A | 83.38 | 10,000 | 833,800 | 10,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Payment of Exercise | F | 83.38 | 492 | 41,023 | 2,659 | 3.2 K to 2.7 K (-15.61 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 0.00 | 1,250 | 0 | 3,151 | 1.9 K to 3.2 K (+65.75 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Option Exercise | A | 83.38 | 40,000 | 3,335,200 | 40,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Payment of Exercise | F | 83.38 | 2,124 | 177,099 | 7,127 | 9.3 K to 7.1 K (-22.96 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | JONES WILLIAM A JR | CCO-Migraine & Comm ... | Buy | M | 0.00 | 5,000 | 0 | 9,251 | 4.3 K to 9.3 K (+117.62 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 1,250 | 0 | 2,187 | 937 to 2.2 K (+133.40 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 5,691 | 7.4 K to 5.7 K (-23.49 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Stock Elyse | Chief Medical Offic ... | Buy | M | 0.00 | 3,750 | 0 | 7,438 | 3.7 K to 7.4 K (+101.68 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 7,691 | 9.4 K to 7.7 K (-18.51 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | SVP, Clinical Opera ... | Buy | M | 0.00 | 3,750 | 0 | 9,438 | 5.7 K to 9.4 K (+65.93 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 9,211 | 11 K to 9.2 K (-15.94 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.00 | 3,750 | 0 | 10,958 | 7.2 K to 11 K (+52.03 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Option Exercise | A | 83.38 | 30,000 | 2,501,400 | 30,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Payment of Exercise | F | 83.38 | 1,747 | 145,665 | 10,012 | 11.8 K to 10 K (-14.86 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Conway Charles | Chief Scientific Of ... | Buy | M | 0.00 | 3,750 | 0 | 11,759 | 8 K to 11.8 K (+46.82 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Option Exercise | A | 83.38 | 100,000 | 8,338,000 | 100,000 | |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Payment of Exercise | F | 83.38 | 5,802 | 483,771 | 19,409 | 25.2 K to 19.4 K (-23.01 %) |
| Jan 08 2021 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 25,211 | 12.7 K to 25.2 K (+98.34 %) |